Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease

NCT00387270 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington's Disease

Interventions

DRUG: Dimebon

Sponsor

Medivation, Inc.

Collaborators

[object Object]